Intranasal Insulin Drug Combo Promising for Alzheimer’s 🔗 Access full article via Medscape NeurologyPositive results of a phase 2 study support the potential to repurpose intranasal insulin and the SGLT2 inhibitor empagliflozin for Alzheimer’s disease. Medscape Medical News Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
